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The Structure of an Engineered Domain-Swapped
Ribonuclease Dimer and Its Implications
for the Evolution of Proteins toward Oligomerization
Introduction
Many proteins have evolved from a monomeric to an
oligomeric form, thereby acquiring new abilities or func-
tions. The structural determinants leading to an oligo-
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Universitat de Girona meric state are, however, difficult to identify because
they might be the sum of many small and subtleCampus de Montilivi
Girona E-17071 changes. Their structural analysis can help us in the
design of new proteins from existing monomers. OneSpain
2 Institut de Biologia Molecular de Barcelona approach to a dimeric association is called domain
swapping [1]. It is based on the mutual exchange of anConsejo Superior de Investigaciones Cientı´ficas
Jordi Girona 18-26 entire domain between each of the molecules of a dimer.
Apart from furthering our pursuit of a protein with novelBarcelona E-08034
Spain abilities, the structural changes derived from single
amino acid substitutions leading to domain swapping
may provide a better understanding of the intriguing
events of molecular evolution.
Two members of the ribonuclease superfamily pro-Summary
vide particularly interesting models for the study of the
transition from a monomer to a domain-swapped dimerBackground: Domain swapping has been proposed as
a mechanism that explains the evolution from mono- with special biological actions. Bovine pancreatic ribo-
nuclease (RNase A) [2] is a small, compact monomericmeric to oligomeric proteins. Bovine and human pancre-
atic ribonucleases are monomers with no biological protein of 124 residues and four disulfide bridges, with
an N-terminal helix (tail, T) that is centrally positionedproperties other than their RNA cleavage ability. In con-
trast, the closely related bovine seminal ribonuclease between the two lobes of a kidney-shaped structure
(body, B). Both domains are connected by a 7 residueis a natural domain-swapped dimer that has special
biological properties, such as cytotoxicity to tumour hinge loop (Figure 1a). Bovine seminal ribonuclease
(BS-RNase), with which RNase A shares 80% of its se-cells. Several recombinant ribonuclease variants are do-
main-swapped dimers, but a structure of this kind has quence identity, is a naturally occurring dimer with both
subunits covalently linked by two disulfide bonds asnot yet been reported for the human enzyme.
well as by noncovalent interactions (Figure 1b; [3]). Two-
thirds of the BS-RNase dimers in seminal plasma haveResults: The crystal structure at 2 A˚ resolution of an
engineered ribonuclease variant called PM8 reveals a their N-terminal domains swapped (M  M quaternary
form), whereas in the rest of the dimers each protomernew kind of domain-swapped dimer, based on the
change of N-terminal domains between the two sub- folds onto itself (M  M quaternary form). BS-RNase
exhibits distinctive catalytic properties (a strong actionunits. The swapping is fastened at both hinge peptides
by the newly introduced Gln101, involved in two intermo- on double-stranded RNA and an allosteric regulation),
as well as other noncatalytic bioactions (immunosup-lecular hydrogen bonds and in a stacking interaction
between residues of different chains. Two antiparallel pressive, aspermatogenic, antiviral, embryotoxic, and
cytotoxic on tumor cells) [3]. Upon lyophilization ofsalt bridges and water-mediated hydrogen bonds com-
plete a new interface between subunits, while the hinge RNase A monomers from acetic acid solution, this dual
ribonuclease system is enriched by the availability ofloop becomes organized in a 310 helix structure.
two forms of artificial domain-swapped dimers (Figure
1c; [4]), for which the three-dimensional structure hasConclusions: Proteins capable of domain swapping
may quickly evolve toward an oligomeric form. As shown been recently determined [5, 6]. Although such dimers
can degrade RNA, they are not endowed with any ofin the present structure, a single residue substitution
reinforces the quaternary structure by forming an open the special bioactions of BS-RNase dimers [7]. Thus,
domain swapping cannot be said to be the only causeinterface. An evolutionary advantage derived from the
new oligomeric state will fix the mutation and favour of special biological activities in the ribonuclease super-
family. A structural comparison suggests that the differ-others, leading to a more extended complementary di-
merization surface, until domain swapping is no longer ent abilities shown by the BS-RNase dimer may arise
from a particular quaternary structure, which in turn isnecessary for dimer formation. The newly engineered
swapped dimer reported here follows this hypothetical derived from the different interactions or interfaces be-
tween the two protomers. The interface between do-pathway for the rapid evolution of proteins.
mains that is present in both the monomer and the do-
3 Correspondence: mcccri@ibmb.csic.es (M.C.),
dbmvb@fc.udg.es (M.V.) Key words: domain swapping; human pancreatic ribonuclease; mo-
lecular evolution; protein oligomerization; site-directed mutagene-4 Both authors have contributed equally to this work and share first
authorship. sis; X-ray crystal structure
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Figure 1. Diagram of Monomeric and Dimeric Ribonucleases
(a) RNase A and its parts.
(b) Natural domain-swapped dimer of BS-RNase.
(c) Artificial domain-swapped minor dimer of RNase A
(d) Two models for the evolutionary process from an RNase monomer to the domain-swapped dimer of BS-RNase (see text). Although present
in all the structures, the closed interface is only indicated in RNase A for clarity. Yellow sticks stand for intermolecular disulfide bonds. M 
M and M  M are the two possible quaternary conformations of natural BS-RNase (see text).
main-swapped oligomer is called the closed interface, and Met29 [4]. BS-RNase has been used as a model to
obtain dimers of related ribonucleases [9, 10]. This iswhereas the interface found only in the oligomer is called
the open interface [8]. not surprising since BS-RNase is the only natural ribo-
nuclease dimer endowed with special noncatalytic bi-The folding pathway of dimeric BS-RNase is attractive
as a plausible description of the evolutionary process oactions, although an alternative model for the evolution
of BS-RNase suggests that different approaches arefrom monomeric to oligomeric proteins in which domain
swapping occurs [4]. Both protomers of BS-RNase are possible.
In contrast to the folding hypothesis, some authorsfolded separately, and in a second step two antiparallel
disulfide bonds are formed between two molecules. The maintain that, given the appropriate partial destabilizing
conditions, a noncovalent dimer may be formed by theresult is a covalently linked dimer, with N-terminal do-
mains still nestling against the bodies formed by their interchange of noncovalently constrained terminal “do-
mains” [1, 6]. A swap early model for the evolution ofown chains. It is from then on that swapping occurs, until
the equilibrium of swapped and non-swapped dimers is intertwined dimers is better suited to the notion that
swapping is a natural event in any case. The interactionsreached. Such a folding pathway may serve as a cova-
lent dimer early model for the evolution of dimers [4], between the exchanged domain and the other subunit
are those that can be found in the monomer and form thewhere domain swapping is the last event (Figure 1d,
upper pathway). According to this model, dimerization closed interface. According to this model, dimerization
can be induced by even a single amino acid substitutionoccurs on the basis of strong interactions located at the
open interface; these interactions are basically the two (Figure 1d, lower pathway). The RNase A domain-swapped
dimers are extreme examples of such a model. Twoantiparallel disulfide bonds (Cys31 and Cys32) and a
reduced hydrophobic patch formed by residues Leu28 dramatically different interfaces are formed in the “mi-
3D Structure of an Engineered Domain-Swapped RNase Dimer
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Figure 2. C Stereo View of Homodimeric
HP-RNase Variant PM8
N-terminal and C-terminal residues have
been labeled with an N and a C, respectively.
Other residues have been labeled with their
number and chain identifier.
nor” (less abundant) and “major” forms of RNase A di- ture with the monomeric ribonucleases of their family if
the hinge peptide (residues 16–22) is excluded from themers, where the N-terminal  helices and C-terminal 
strands, respectively, are exchanged. It has been sug- comparison. This kind of noncovalent protein associa-
tion has already been described for the artificial minorgested that a single mutation that provided stronger
interactions along a newly formed open interface would dimer of RNase A, although the attained quaternary
structure is quite different [5]. Whereas RNase A had toproduce a natural and more stable RNase dimer once
the swapping had occurred [5]. be liophylized in acetic acid to favour dimerization be-
fore crystallization, PM8 crystals were grown with noHuman pancreatic ribonuclease (HP-RNase) [11] is a
monomeric ribonuclease for which no special bioactions previous treatment of the sample.
The overall size of the dimer is 40 A˚ 40 A˚ 70 A˚. Bothhave been reported. Focussing on the basis of the struc-
tural and functional determinants of BS-RNase, Piccoli subunits have the same secondary-structure elements,
which are in turn the elements that have been describedet al. [10] designed and constructed a dimeric variant
of HP-RNase that was found to be cytotoxic to several for a monomeric HP-RNase variant called PM7 [13]. As
shown in Figure 3, both chains exhibit three helices (1,malignant mouse and human cell lines. Here we report
the structural characterization of a different dimeric vari- 2, and 3) and seven  strands (1–7). Helices 1 and
2 are connected by the hinge peptide, which containsant of HP-RNase, called PM8, that strongly supports
the swap early model of dimerization. A single change two consecutive turns and therefore forms a 310-helical
structure encompassing residues 18–23. Strand 1 is(P101Q) was introduced in the sequence of a monomeric
variant of HP-RNase, in which the N-terminal region located between the helices 2 and 3, and the rest of
the strands are located, in sequence, after helix 3.and hinge loop were those of the BS-RNase [12]. The
substitution, which was carried out in the region where Strands 3 and 4 as well as 5 and 6 run anti-parallel
and form a twisted  sheet defining the V-shaped cleftsome residues of the RNase A interact to form the open
interface of the minor dimer, turned out to be a crucial where the active site is located. Helices2 and3 further
delimitate the cleft. Both subunits have four intramolec-step toward dimerization. It resulted in the formation of
a domain-swapped dimer with a quaternary structure ular disulphide bonds at positions 26–84, 40–95, 58–110,
that has hitherto not been described in ribonucleases. and 65–72. Such bonds are a normal feature in the mem-
bers of the RNase superfamily. Although when com-
pared to RNase A PM8 has two extra proline residuesResults
(positions 19 and 50), the only X-Pro bonds that have a
cis conformation are those that have one in the bovineOverall Structure
enzyme (positions 93 and 114).Human pancreatic ribonuclease PM8 forms dimers with
Very few differences are detected when both subunitsno covalent unions between both chains (A and B). The
are superimposed (rmsd of 0.7 A˚ when all the C atomsinterchange of entire domains between both subunits
are used). Both domains can be superimposed at onceis the basis of the dimeric structure. As shown in Figure
since there is no shift between the tail domains, as was2, the N-terminal domain (or tail, T; residues 1–15) of
observed in the BS-RNase dimer by Mazzarella et al.each subunit is nestling against the C-terminal domain
[15]. The symmetry operation that relates both subunits(or body, B; residues 23–128) of the other. Such domain
is defined by spherical polar angles  91.4,φ 24.1,swapping generates two composite units (TA/BB and
TB/BA) that can be considered to share their overall struc-   179.5, and a translation of (x, y, z)  (2.1, 5.8,
Structure
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Figure 3. Sequence Alignment and Second-
ary-Structure Elements of Domain-Swapped
Dimeric RNases
(a) Structure-based alignment of the se-
quences from human pancreatic ribo-
nuclease variant PM8 (present structure),
wild-type human pancreatic ribonuclease
(HP-RNase), bovine seminal ribonuclease
(BS-RNase) and bovine pancreatic ribo-
nuclease (RNase A). Sequence differences
between PM8 and HP-RNase are boxed in
black. The hinge loop region is boxed in
green. Purple boxes show residues involved
in the open interface of domain-swapped di-
mers exchanging their N-terminal  helices.
The secondary-structure elements of PM8
( strands, ;  helices, ; 310-helices, 310; and
turns, T) are graphically represented and
were calculated with the program PRO-
CHECK [35] and DSSP [41]
(b) Ribbon representations of HP-RNase vari-
ant PM8, RNase A minor dimer, and BS-
RNase dimer. Secondary structure elements
of PM8 are labeled according to (a), with heli-
ces, strands, and loops shown as helical rib-
bons, arrows, and thin tubes, respectively.
3D Structure of an Engineered Domain-Swapped RNase Dimer
971
18.0) A˚ [16]. Loop 45 (residues 87–96) is disordered interface. The substitution of the Pro101 for a Gln in
PM8 enhances the stability of the hinge peptide andin molecule B, and therefore cannot be compared with
the same region of molecule A. Deviations larger than also takes part in the formation of the open interface.
Clear hydrogen bonds are found between atoms of both1.0 A˚ can only be measured around residues 66 and 69
of loop 23, with a maximum of 1.98 A˚. If one excludes chains as a result of the substitution. Each Gln101 resi-
due establishes three H bonds, one between its amidethese two loop regions, the rmsd between both subunits
is 0.3 A˚. N atom and the O	 atom of Ser20 of its own chain, the
other two between its O
1 atom and the N and O	 atomsThe main difference between both composite active
sites is the alternate conformation of the active site of Ser20 of the other subunit (Figures 4b and 5). More-
over, Gln101 participates in a stacking interaction thatHis119 in chain B, at the TA/BB structural unit. The two
conformations, known as up and down, have been pre- involves different residues of both chains. The two Pro19
residues of the dimer are stacked between the sideviously found in other RNase A structures [14]. The down
conformation is the only form found in the structure chains of residues Gln101 and Tyr25 of the other chain
(Figure 4b). The interactions between subunits are there-of the closely related monomeric PM7 [13]. The only
significative disagreement between both subunits at the fore stronger, and the stability of the hinge peptide is
improved by four H bonds that could not be establishednon-catalytic subsites is the position of Lys66, at the p0
subsite. In fact, the divergence arises from the different if residue 101 were a proline.
The interactions described above play the role of aconformation of the whole loop 23 in chains A and
B. The average temperature factor is 26.0 A˚2 for chain secondary anchor point, after the formation of the
closed interface between T and B domains, and deter-A and 25.2 A˚2 for chain B.
mine the relative orientation of both subunits to some
extent. The final quaternary structure is attained when,Hinge Peptides
as a result of this particular orientation, two antiparallelBoth hinge peptides (residues 16–22) have the same
ionic interactions take place between residues of differ-conformation. This is a unique feature in known dimeric
ent chains. The Glu103 residues of each subunit estab-ribonucleases with intertwined N-terminal  helices. Al-
lish a salt bridge with the Arg104 residues of the otherthough the model used for the molecular replacement did
(Figure 5). The distances between atoms OE2 and NH1not include the atomic coordinates for residues 18–21, the
of the ionic pairs are 2.9 A˚ for Glu103A-Arg104B andstructure of both hinge peptides clearly showed up in the
3.0 A˚ for Arg104A-Glu103B. In fact, both residues areearliest refinement cycles of PM8. The low temperature
located in the same  strand (5) that is involved in thefactors found for residues 19 and 20 (around 26 A˚2)
formation of the open interface of the minor RNase Aconfirm that it is a well-ordered region. Although our
domain-swapped dimer [5], although the interactionsdimer shares the primary sequence of the hinge peptide
are of a different nature. These are the only direct con-with BS-RNase, it has a different structure. There are
tacts between the two subunits—apart from those thattwo contiguous turns in the middle of the linker peptides
form the closed interface and the interactions at thebetween residues 18 and 23, so that the hinge loop
hinge peptide—although several water-mediated hydro-in fact adopts a 310 helix conformation. Both turns are gen bonds are also observed along the open interface.stabilized by multiple-centred H bonds (Figure 4). The
helical structure is capped by H bonds between O	
atoms of serine residues 21 and 22, and the amide nitro- Nondenaturing Cathodic Electrophoresis
gen atoms of Ser18 and Ser21, respectively. Several and RI Binding Assays
kinds of turns have been described in hinge loops of PM8 dimers are not restricted to the crystal state. Non-
different ribonucleases [17], but a clear helical structure denaturing cathodic electrophoresis reveals that oligo-
has only been found in one of the linking peptides of meric forms of PM8 may be found when the protein is
artificial RNase A domain-swapped minor dimer. in solution (Figure 6). Although the monomer is quantita-
The presence in PM8 of a Pro residue at position 19, tively the major form, at least two more bands appear
together with a Gly at position 16, provides the minimum when the amount of protein loaded onto the gel is large
requirements for a natural swapping of N-terminal re- enough (10 g). The major form is assigned to the PM8
gions. The hinge peptides of BS-RNase and HP-RNase monomer as it comigrates with the monomeric control
differ only in two residues (positions 16 and 17; see (RNase A). The other two forms have a slower electro-
Figure 2a). Both proteins have a Pro residue at position phoretic mobility than the monomer and may be assigned
19, which is necessary for a natural swapping [18], but to putative PM8 oligomers. The structure described in the
BS-RNase has a distinctive Gly at position 16 that is present work may correspond to one of these slowly
likely to provide the necessary degree of freedom for the moving forms of PM8.
change of conformation. In fact, the position of Gly16B is Cytotoxicity is one of the biological actions acquired
uncertain in PM8 due to its mobility. by BS-RNase upon dimerization [4]. The cytotoxic ef-
fects have been related to the ability of BS-RNase to
evade the proteic ribonuclease inhibitor (RI) [19] as aOpen Interface
There are no significant differences among the closed result of its quaternary structure. The interaction of RI
with the PM8 HP-RNase variant has been tested in aninterfaces of the N-terminally swapped RNase dimers
that have been published to date [5, 6, 15]. Thus, varia- agarose gel-based assay. Under assay conditions, PM8
is inhibited by RI to the same extent as RNase A andtions in the overall quaternary structure are a conse-
quence of the interactions taking place along the open PM7 [13]. However, the PM8 concentration in the assay
Structure
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Figure 4. Structure of the Hinge Peptide and Interaction with Gln101
Stereo views of (a) the hinge peptide in chain A forming a 310 helix structure and (b) the H bonds and stacking interactions between Gln101
and residues Pro19 and Ser20 (see text). The final A 2Fo  Fc electron density maps (contoured at 1.0 ) and the refined model are presented
in both images. Red dashed lines indicate hydrogen bonds. Chains A and B are colored green and purple, respectively.
is very low, and thus the oligomeric population may be A minor dimer is probably difficult to attain as well since
enzymatically undetectable. the interactions along two neighboring 5 strands would
be of a different nature as a result of the aminoacid
sequence of PM5 (see Figure 3a). The substitution of aDiscussion
Pro at position 101 by a Gln (as in strand 5 of RNase
A) in PM8 enables new interactions at a new open inter-From a Preevolved Hybrid to a Hybrid Dimer
face to promote the formation of a never-reported di-PM8 is a single-residue variant of an engineered protein
meric structure, half way between the natural BS-RNasecalled PM5, which has a hybrid amino acid sequence
dimer [15] and the artificial RNase A minor dimer [5].between BS-RNase (tail domain and hinge peptide) and
Apart from the obvious similarity in the closed inter-HP-RNase (body domain) [12]. PM5 may be considered
faces, dimeric PM8 has features in common with botha preevolved protein since it has the appropriate hinge
domain-swapped RNase dimers. These features arisepeptide sequence for natural domain swapping [18], in
from the swapping and quaternary-structure determi-addition to a tail domain that may interact with the body
nants that PM8 shares with them. As in the BS-RNasedomain of a neighboring molecule. Because an N-terminal
dimer, the exchange of N-terminal domains occurs inexchange is favored in PM5, one might expect the forma-
PM8 on opposite sides of the dimeric structure (seetion of either a dimer resembling the M  M BS-RNase
Figure 1). This kind of exchange is probably favored byform or the RNase A minor dimer. A BS-RNase-like dimer
the rigid structure of the hinge peptide, which has ancannot be achieved due to the lack of cysteines 31 and
identical amino acid sequence in both dimers. In the32, which form two intersubunit disulfide bonds in the
seminal enzyme. A structure such as that of the RNase RNase A minor dimer the exchange of N-terminal do-
3D Structure of an Engineered Domain-Swapped RNase Dimer
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peptide. Their dimer was assumed to have a similar
structure to that of the RNase A dimer. However, as shown
in the present work, other quaternary conformations can
be attained, which could be the case for Russo’s dimer
as well.
There are at least two conformations of dimeric RNase
A, and they can be separated by nondenaturing cathodic
electrophoresis, size-exclusion chromatography [23], or
ion-exchange chromatography [24]. Eisenberg et al. have
reported the three-dimensional structure of both RNase
A dimer forms [5, 6]. They have shown that the minor
dimer form is based on the exchange of the N-terminal
 helices, whereas the C-terminal  strands are the ex-
changed elements in the major form. Thus, it is possible
to obtain more than one open interface that has a differ-
ent quaternary structure even when no substitutions
are made. Recently, Park and Raines have detected a
recombinant RNase A dimer at neutral pH, which sug-
gests that RNase A has an intrinsic ability to form a
functional domain-swapped dimer even in physiological
conditions [25]. The three-dimensional structure of this
dimer remains unknown.
Dimers in Solution, RNase Activity,
and Resistance to RI
Although most PM8 molecules exist in the monomeric
form when they are in solution at different pH and protein
concentration values, the presence of a few dimeric
or oligomeric forms is also confirmed. The interactions
found along the open interface of our dimer are too
Figure 5. Interactions Along the Open Interface weak to ensure an important population of dimeric HP-
Detail of the region squared in Figure 2b shows a schematic repre- RNase in solution. Ionic strength may affect the stability
sentation of the interactions that take place in the open interface. of the dimer since the union is partially based on two
Red dashed lines indicate intermolecular and intramolecular hydro-
electrostatic interactions. These interactions could begen bonds between Gln101 residues and Ser20 residues of both
favored by the low dielectric constant of the precipitantchains. Antiparallel ionic pairs (residues Glu103 and Arg104 of both
chains) are depicted with white spheres labeled with their corre- solution.
sponding charge sign. Both composite active sites of dimeric PM8 are poten-
tially functional, as the architecture of each is identical
to that of its monomeric relative, PM7 [13]. However,
mains takes place along the same side of the quaternary the ability of the dimer to cleave RNA cannot be con-
structure. As a result of the residue substitution (P101Q), firmed. The monomeric population of the protein, which
the new open interface formed in PM8 resembles that is quantitatively more important and difficult to separate,
of the RNase A dimer. Adjoining residues are in both hampers an accurate analysis of its catalytic properties.
cases located in strand 5 (residues 97–104; see Figure Unlike dimeric BS-RNase, our variant is RI sensitive,
3a), although the nature of the interactions that maintain as shown by binding assays. This means that PM8 is
the quaternary conformation is rather different. In BS- not able to degrade RNA when the ribonuclease inhibitor
RNase, the open interface is formed primarily between is present. The PM8 concentration is very low in the
two  helices (residues 24–33). interaction assay, and under this condition the oligo-
meric forms could be undetectable. RI binding of
Diverse Open Interfaces Are Attainable RNases is mainly located at loops 21, 23, and 45
As Eisenberg et al. proposed in their description of the of the enzyme [26, 27], and the quaternary structure of
RNase A domain-swapped minor dimer [5], mutations BS-RNase may prevent the union since access to loops
can influence the nature of the open interface and hence 21 and 45 is blocked. Our dimeric structure is un-
the overall structure of ribonuclease dimers. The dimeric likely to evade the RI because access to these loops is
structure of PM8 confirms this idea since a Gln at posi- possible, at least for one RI molecule. The binding of a
tion 101 influences the nature of the open interface. This second RI molecule to ensure the blocking of the second
single substitution affects the conformation of the hinge active site of PM8 is not possible due to steric hindrance,
peptide as well by promoting the formation of a 310 helix unless the overall quaternary conformation of the dimer
structure. This helical structure shortens the distance is altered. However, it is possible that even an initial
between the tail and body domains. Hinge loop shorten- complex with one RI molecule alters the structure in such
ing is a common strategy for obtaining domain-swapped a way that both composite active sites become nonfunc-
dimers [20, 21], and Russo et al. [22] obtained a stable tional or, alternatively, the dimer is dissociated and the
equilibrium is displaced toward the monomeric form.HP-RNase dimer by deleting 3–5 residues from the hinge
Structure
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Figure 6. Denaturing and Nondenaturing Ca-
thodic Electrophoresis Gels of Protein PM8
in Solution
Only one band appears when 10g of protein
PM8 at 10 mg/ml is loaded onto a SDS-PAGE
gel. At least three bands appear when the
same amount of protein is loaded onto a non-
denaturing cathodic electrophoresis gel, al-
though the major part of the sample can be
assigned to the monomeric form by compari-
son of its electrophoretic mobility with that
of control RNAse A (four residues shorter than
PM8, and with a slight tendency to dimerize
as can be seen on the gel). Slowly moving
bands can therefore be assigned to oligo-
meric associations of PM8.
Molecular Evolution teed and can play the role of a primary anchor point. From
then on, very few mutations will be needed to reinforceThe domain swapping in PM8 provides clues on how to
promote protein association and widen the availability the union with a new interface between subunits.
The crystal structure of RNase PM8 proves that a newof new and different quaternary conformations that may
be of biological interest. As in the swap early model for
the evolution of intertwined dimers [1], domain inter-
Table 1. Data Collection and Refinement Statisticschange in PM8 is an event that has been fixed with
a single amino acid substitution (P101Q). This single Data Collection
mutation fastens the swapping in PM8 (hydrogen bonds
Resolution range (A˚) 13.0–2.0and stacking interactions with residues in the hinge loop)
Completeness (%) 99.4 (98.8)
while promoting the formation of a new open interface Number of observed reflections 56,729
nearby (antiparallel ionic pairs between residues 103 Number of unique reflections 16,247
and 104). Accordingly, an almost simultaneous en- Rmerge1 (%) 7.6 (31.5)
I/I 7.1 (2.4)hancement of swapping and covalent union formation
Multiplicity 3.4 (3.1)is assumed in a model for the pathway from a monomeric
to a dimeric form of BS-RNase [28], which is consistent Refinement
with the reconstructed evolutionary history of the semi-
Number of reflections in working set 14,635
nal RNase gene family. Our dimer is also consistent with Number of reflections in test set 1,610
the model proposed by Park and Raines [25], which Number of protein atoms in the asym. unit 1,987
implies a continuous evolution performed on an unstable Number of solvent molecules in the asym. unit 342
R2, Rfree3 (%) 19.6, 24.3form in physiological conditions until the formation of a
Rms deviations from target valuesmore stable dimer is reached.
Bond lengths (A˚) 0.006Hence, a swap early model is better suited for the
Bond angles () 1.565
in vitro evolution of our dimer. An additional mutation Average B factors (A˚2)
fastening the now rather fragile open interface of PM8 Main chain 25.6
would probably produce a more abundant dimeric form Side chain 27.1
Water molecules 42.0in solution and perhaps a different quaternary structure
All atoms 28.7endowed with new biological activities.
Wilson plot 25.4
Ramachandran statistics (%)
Biological Implications Most-favored regions 88.2
Additionally allowed regions 11.8
To gain a deeper insight into molecular evolution, one Generously allowed regions 0.0
Disallowed regions 0.0must understand the structural basis of protein oligo-
merization. The protein association known as “domain 1 Rmerge  |Ih  Ih|/Ih, where Ih is the average of intensity
swapping” offers a fast way to evolve from a monomer of reflection h and their symmetry related reflections.
2 R  ||Fo|  |Fc||/|Fo|.to a stable oligomer with new biological actions. Because
3 Rfree  R–value calculated for 10% of reflections not used for thethey are based on the interchange of complete secondary
refinement. The outermost resolution shell (2.12–2.00 A˚) values areelements between identical molecules, the interactions
shown in parentheses.
that take place between intertwined regions are guaran-
3D Structure of an Engineered Domain-Swapped RNase Dimer
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nated side chain conformations were built for residues 32, 75, and 91dimeric structure can be attained by only one residue
of molecule A and for residues 78, 100, and 119 of molecule B.change. The substitution of residue Pro101 by a glutamine
The final model contains 342 molecules of water and has an Renables the formation of four additional hydrogen bonds
factor of 0.196 and an Rfree of 0.243. Refinement statistics are shownand a stacking interaction that strengthens the domain- in Table 1. The structure has excellent geometry, as was validated
swapped structure at the hinge peptide and determines with PROCHECK [35]. B factor statistics were calculated with BAV-
ERAGE from the CCP4 package [36]. Least squares superpositionsthe relative position of both subunits. As a result of this
were performed with TURBO. Figures were drawn with TURBO andparticular orientation, two intermolecular salt bridges
MOLMOL [37].that fasten the quaternary structure are established.
Although other domain-swapped dimers have been
Detection of Dimeric Forms in Solution and Ribonucleasedescribed in the ribonuclease superfamily, the overall
Inhibitor Binding Assay
structure of dimeric PM8 is new. The achievement of this Pure samples of PM8 and monomeric RNase A (as a control) were
swapped dimer validates a strategy for rapidly changing analyzed by cathodic gel electrophoresis under nondenaturing con-
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of 10 g of protein at a 10 mg/ml concentration was loaded onto a
nondenaturing gel. Loading the same amount of protein onto SDS-Experimental Procedures
PAGE gels [39] confirmed the purity of the sample.
The ribonucleolytic activity of PM8 in the presence of porcineSample Preparation
RI was tested with an agarose gel-based assay according to theProteins PM5 and PM8 come from the expression of a hybrid gene
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